SCHEMBL2648631

SCHEMBL2648631

CCCc1c(C(C)C)cc(C(C)C)c(C(C)O)c1-c1ccc(F)cc1OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 8/20 0.57
L3MBTL1 Q9Y468 2/20 0.45
FFAR4 Q5NUL3 3/20 0.38
USP2 O75604 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
CCNT1 O60563 2/20 0.35
CDK2 P24941 2/20 0.35
CDK9 P50750 2/20 0.35
CCNA2 P20248 1/20 0.35
CCNA1 P78396 1/20 0.35
FFAR1 O14842 2/20 0.35
CCNE1 P24864 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2646478 0.89 L3MBTL1 (0.47) GCGRL3MBTL1FFAR4USP2TDP1
SCHEMBL2648891 0.83 L3MBTL1 (0.46) GCGRL3MBTL1FFAR4USP2TDP1
SCHEMBL2647755 0.80 GCGR (0.71) GCGR
SCHEMBL2649450 0.76 L3MBTL1 (0.47) L3MBTL1FFAR4USP2TDP1CCNT1
SCHEMBL2648389 0.76 L3MBTL1 (0.40) L3MBTL1FFAR4USP2TDP1ALDH1A1
SCHEMBL2648392 0.76 L3MBTL1 (0.40) L3MBTL1FFAR4USP2TDP1ALDH1A1
SCHEMBL30661851 0.74 GCGR (1.00) GCGR
SCHEMBL105891 0.74 GCGR (1.00) GCGR
SCHEMBL2648665 0.73 FFAR4 (0.47) L3MBTL1FFAR4USP2TDP1LMNA
SCHEMBL2650211 0.73 GCGR (0.69) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed